Article info

PDF
Short report
CHEK2*1100delC homozygosity is associated with a high breast cancer risk in women
  1. Correspondence to Dr Q Waisfisz, VU University Medical Centre, Amsterdam, Department of Clinical Genetics, section Oncogenetics, Van der Boechorststraat 7, 1081 BT Amsterdam, The Netherlands; q.waisfisz{at}vumc.nl
View Full Text

Citation

Adank MA, Jonker MA, Kluijt I, et al
CHEK2*1100delC homozygosity is associated with a high breast cancer risk in women

Publication history

  • Received July 27, 2011
  • Accepted October 13, 2011
  • First published November 5, 2011.
Online issue publication 
November 21, 2011

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.